Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies
Authors:
- Klaus PfizenmaierKPKlaus Pfizenmaier
- Michael SchroederMSMichael Schroeder
- Gerd A. NagelGNGerd A. Nagel
- 1 February 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (2) , 287-291
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tumor necrosis factor in experimental cancer regression with alphatocopherol, beta-carotene, canthaxanthin and algae extractEuropean Journal of Cancer and Clinical Oncology, 1988
- Phase I clinical trial of recombinant human tumor necrosis factorCancer Chemotherapy and Pharmacology, 1987
- Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibitionAnnals of Hematology, 1987
- Serum-free in vitro bioassay for the detection of tumor necrosis factorJournal of Immunological Methods, 1986
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Tumor Necrosis Factor (TNF)Science, 1985
- Human tumor necrosis factor. Production, purification, and characterization.Journal of Biological Chemistry, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceInternational Journal of Cancer, 1984